Nouveau Life Pharmaceuticals, Inc.
NOUV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$666.1K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $666,096.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -0.49 |
| Outstanding Shares | 6,660,963,733 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -38.7 |
|---|---|
| PEG | 313.46 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nouveau Life Pharmaceuticals, Inc.
0CEO: Brian Shibley
Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations...